Skip to main content

Schizophrenia trials in China: a survey

Buy Article:

$48.00 plus tax (Refund Policy)


Chakrabarti A, Adams CE, Rathbone J, Wright J, Xia J, Wong W, Von Reibnitz P, Koenig C, Baier S, Pfeiffer C, Blatter J, M. Mantz M, Kloeckner K. Schizophrenia trials in China: a survey. Objective: 

China's biomedical research activity is increasing and this literature is becoming more accessible online. Our aim was to survey all randomized control schizophrenia trials (RCTs) in one Chinese bibliographic database. Method: 

Chinese Academic Journals was electronically searched for RCTs and all relevant citations were also sought on PubMed to ascertain global accessibility. Results: 

The search identified 3275 records, of which 982 were RCTs relevant to schizophrenia. A total of 71% (699) could be found by using English phrases. All the main body of text of the 982 papers was in Mandarin. On average, these trials involved about 100 people, with interventions and outcome measures familiar to schizophrenia trialists worldwide. Four of the 982 records (<1%) were identified on PubMed. Conclusion: 

Those undertaking systematic reviews should search the Chinese literature for relevant material. Failing to do this will leave the results of systematic reviews prone to random error or bias, or both.

Keywords: China; randomized controlled trial; schizophrenia

Document Type: Research Article


Affiliations: 1: General Adult Psychiatry, Newsam Centre, Seacroft Hospital, York Road, Leeds, West Yorkshire 2: Academic Unit of Psychiatry and Behavioural Sciences, University of Leeds, Leeds, UK 3: Schule für Medizinische Dokumentation, University of Ulm, Ulm, Germany

Publication date: July 1, 2007


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more